See the DrugPatentWatch profile for adderall
Lannett Adderall XR refers to the extended-release formulation of amphetamine salts, historically manufactured by Lannett Company, Inc. This medication is used to treat Attention-Deficit/Hyperactivity Disorder (ADHD) and narcolepsy.
What is Lannett's role with Adderall XR?
Lannett was a generic pharmaceutical company that manufactured and distributed various drug products, including a generic version of Adderall XR. The company faced significant regulatory and manufacturing challenges in the years leading up to its bankruptcy. In 2023, Lannett announced it had ceased all operations and filed for Chapter 11 bankruptcy protection [1].
When did Lannett's generic Adderall XR become available?
The availability of generic Adderall XR, including Lannett's version, followed the patent expiry of the brand-name drug. The original Adderall XR was developed by Shire, which was later acquired by Takeda. Generic versions typically become available after the expiration of relevant patents and exclusivities.
What are the challenges with Adderall XR supply?
The supply of Adderall XR, both brand-name and generic, has been subject to significant disruptions. These issues have been attributed to a complex interplay of factors, including manufacturing capacity limitations, increased demand, and Drug Enforcement Administration (DEA) production quotas [2]. These shortages have impacted patients' ability to access their prescribed medication.
Who else manufactures Adderall XR?
Teva Pharmaceuticals is a primary manufacturer of the brand-name Adderall XR. Other generic manufacturers also produce extended-release amphetamine salts that are therapeutically equivalent to Adderall XR. The U.S. Food and Drug Administration (FDA) maintains information on approved drug products and their manufacturers.
How does generic Adderall XR differ from the brand name?
Generic versions of Adderall XR, including those previously produced by Lannett, are required to meet the same FDA standards for safety, quality, and strength as the brand-name product. They contain the same active ingredients and are designed to work in the same way. The primary difference typically lies in the inactive ingredients and the manufacturer.
What is the patent status of Adderall XR?
The original patents protecting Shire's Adderall XR have expired, allowing for the production of generic versions. However, pharmaceutical companies often pursue additional patent protection for formulations, manufacturing processes, or new uses, which can extend market exclusivity. Information on specific patent expirations and potential future exclusivities can be found through resources like DrugPatentWatch.com [3].
What are the side effects of Adderall XR?
Common side effects associated with Adderall XR can include decreased appetite, dry mouth, insomnia, weight loss, increased blood pressure, and increased heart rate. More serious side effects may also occur and patients should consult with their healthcare provider regarding potential risks and management strategies.
Sources:
1. https://www.drugpatentwatch.com/blog/lannett-files-for-bankruptcy-exits-operations
2. https://www.drugpatentwatch.com/blog/understanding-the-adderall-shortage
3. https://www.drugpatentwatch.com/